Looking deeper

The ACCC is investigating whether the proposed merger of Arrow and Apotex – two of the largest suppliers of generics in Australia – will impact on competition In early May, Arrow and Apotex announced a proposed merger of their Australian and New Zealand generic pharmaceutical and OTC operations. The Australian Competition and Consumer Commission (ACCC)